Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.8 AUD | +2.86% | +2.86% | -6.49% |
Mar. 19 | Cyclopharm's Technegas Device Carries Out Imaging of First US Patients | MT |
Mar. 18 | Cyclopharm Limited(ASX:CYC) added to S&P/ASX All Ordinaries Index | CI |
Business Summary
Number of employees: 87
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Technegas
100.0
%
| 23 | 98.5 % | 26 | 100.0 % | +15.13% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Europe
56.2
%
| 12 | 52.4 % | 15 | 56.2 % | +21.76% |
Asia Pacific
32.9
%
| 8 | 33.6 % | 9 | 32.9 % | +11.27% |
Canada
10.4
%
| 3 | 12.7 % | 3 | 10.4 % | -7.50% |
Other
0.4
%
| 0 | 1.3 % | 0 | 0.4 % | -60.87% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
James McBrayer
CEO | Chief Executive Officer | 58 | 08-06-02 |
Mathew Farag
COO | Chief Operating Officer | - | 16-12-31 |
Mark Doverty
PRN | Corporate Officer/Principal | - | 19-09-29 |
Sales & Marketing | - | 19-09-29 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dianne Angus
BRD | Director/Board Member | 63 | 21-08-09 |
James McBrayer
CEO | Chief Executive Officer | 58 | 08-06-02 |
David Heaney
CHM | Chairman | 79 | 06-11-19 |
Kevin Barrow
BRD | Director/Board Member | - | 22-08-31 |
Gregory King
BRD | Director/Board Member | - | 22-09-26 |
Director/Board Member | - | Feb. 18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 94,096,326 | 42,486,087 ( 45.15 %) | 0 | 45.15 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.49% | 107M | |
+8.33% | 219B | |
+6.72% | 183B | |
+10.18% | 132B | |
+24.91% | 106B | |
-1.63% | 62.09B | |
+10.56% | 50.8B | |
+4.81% | 50.88B | |
-0.24% | 40.64B | |
+1.22% | 35.71B |
- Stock Market
- Equities
- CYC Stock
- Company Cyclopharm Limited